Using cell engineering and microbiology to find solutions to long standing medical and patient needs to include pain treatment, cancer and vaccines, Neurocarrus is a biotech company current strucctured around developmen of a novel drug delivery technology safely to disrupt pain signals without addiction-forming medications or disruption of muscular control. Designated N-001, the firm describe what they have as a first-in-class therapeutic designed to treat the physiological symptoms of pain while avoiding systemic absorption and invasive surgical procedures.
